Keith C. Kummerfeld - Dec 9, 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Vice President of Finance and Corporate Controller
Signature: /s/ Ilan Katz, attorney-in-fact
Stock symbol: ARCT
Transactions as of: Dec 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/16/2022, 05:28 PM
Previous filing: Jun 23, 2022
Next filing: Apr 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARCT	Employee Stock Option (right to buy)	Award	$0	+40K		$0.00	40K	Dec 9, 2022	Common Stock	40K	$16.92	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2	The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.

Remarks:

Vice President of Finance and Corporate Controller